Canada’s Drug Agency (CDA-AMC) recommends that Keytruda be reimbursed by public drug plans for the treatment of adult patients with
Immune checkpoint inhibitor–based therapies, especially dual immune checkpoint inhibitor regimens, are now frequently used as initial treatments for advanced or
Sexual dysfunction, including erectile dysfunction (ED) is a common problem for males starting in their early 40s and increases with
Canada’s Drug Agency (CDA-AMC) recommends that Enhertu be reimbursed by public drug plans for the second-line treatment of adult patients
Synthetic data has been gaining popularity in many fields as an approach to retain data utility (the validity of inference
Registration No: 771800548 Contact Number : +91-8249516996
